Saltra™

Saltra™

Therapeutic Segment: Anti-Asthmatic

Generic Name: Salmeterol + Fluticasone

Indication:

Asthma (Reversible Obstructive Airways Disease):

For the regular treatment of asthma (Reversible Obstructive Airways Disease). This may include:

– Patients on effective maintenance doses of long-acting ß agonists and inhaled corticosteroids.

– Patients who are symptomatic on current inhaled corticosteroid therapy.

– Patients on regular bronchodilator therapy who require inhaled corticosteroids.

Chronic Obstructive Pulmonary Disease (COPD):

For the regular treatment of Chronic Obstructive Pulmonary Disease (COPD) including chronic bronchitis and emphysema.

Available as:

Metered Dose Inhaler
  • 25mcg + 125mcg
  • 25mcg + 250mcg